Robichaud L J, Wurster S, Boxer P A
Department of Neuroscience Pharmacology, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co., Ann Arbor, MI 48105.
Brain Res. 1994 Apr 18;643(1-2):352-6. doi: 10.1016/0006-8993(94)90047-7.
The ability of VSCC antagonists to modulate excitatory amino acid (EAA) release was evaluated by measuring N-methyl-D-aspartate (NMDA) receptor-dependent spontaneous epileptiform discharges in rat cortical wedges. The N-type channel blocker omega-CTX-GVIA (300 nM) was ineffective. The P-type channel blocker omega-Aga-IVA at 300 nM reduced the frequency of discharges by 63%, while 300 nM omega-CTX-MVIIC reduced the frequency by 35%. These results coupled with the absence of NMDA antagonism by omega-Aga-IVA or omega-CTX-MVIIC in the cortical wedge suggest that the VSCCs blocked by these toxins are primarily responsible for mediating impulse dependent EAA release in the rat neocortex.
通过测量大鼠皮质楔形切片中N-甲基-D-天冬氨酸(NMDA)受体依赖性自发性癫痫样放电,评估电压门控性钙通道(VSCC)拮抗剂调节兴奋性氨基酸(EAA)释放的能力。N型通道阻滞剂ω-CTX-GVIA(300 nM)无效。300 nM的P型通道阻滞剂ω-Aga-IVA使放电频率降低了63%,而300 nM的ω-CTX-MVIIC使放电频率降低了35%。这些结果,再加上在皮质楔形切片中ω-Aga-IVA或ω-CTX-MVIIC不存在NMDA拮抗作用,表明被这些毒素阻断的VSCC主要负责介导大鼠新皮质中冲动依赖性EAA的释放。